| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CALB2
|
calbindin 2
|
|
CCNE1
|
cyclin E1
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFB4A
|
defensin, beta 4A
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EPHA2
|
EPH receptor A2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
HOXA11
|
homeobox A11
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL6R
|
interleukin 6 receptor
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
LIF
|
leukemia inhibitory factor
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIR182
|
microRNA 182
|
|
MUC1
|
mucin 1, cell surface associated
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
OLFM1
|
olfactomedin 1
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAX8
|
paired box 8
|
|
PGR
|
progesterone receptor
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PRLR
|
prolactin receptor
|
|
PROKR1
|
prokineticin receptor 1
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
RGS16
|
regulator of G-protein signaling 16
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TLR10
|
toll-like receptor 10
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TP53
|
tumor protein p53
|
|
VEGFA
|
vascular endothelial growth factor A
|
